Page last updated: 2024-09-03

pn 202-791 and san 202791

pn 202-791 has been researched along with san 202791 in 1 studies

Compound Research Comparison

Studies (pn 202-791)	Trials (pn 202-791)	Recent Studies (post-2010) (pn 202-791)	Studies (san 202791)	Trials (san 202791)	Recent Studies (post-2010) (san 202791)
44	0	1	31	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kan, E; Kelly, JE; Lokuta, AJ; Nishio, M; Sagawa, K; Sagawa, T; Tsai, J; Wasserstrom, JA	1

Other Studies

1 other study(ies) available for pn 202-791 and san 202791

Article	Year
Activation of purified cardiac ryanodine receptors by dihydropyridine agonists. American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:3 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Dogs; Membrane Potentials; Myocardium; Nicotinic Acids; Nifedipine; Oxadiazoles; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Stereoisomerism	2001

Article

Year

Activation of purified cardiac ryanodine receptors by dihydropyridine agonists.

American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:3

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Dogs; Membrane Potentials; Myocardium; Nicotinic Acids; Nifedipine; Oxadiazoles; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Stereoisomerism

2001